UNSPSC 51383406: Proglumetacin maleate

This classification denotes an indoleacetic acid and non-steroidal anti-inflammatory agent with the molecular formula C46H58ClN5O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FV919079LU, chemically known as 3-(4-(2-hydroxyethyl)-1-piperazinyl)propyl dl-4-benzamido-n,n-dipropylglutaramate 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate (ester) but more generally known as proglumetacin, which bears US NIH Compound Identifier 4921.

UNSPSC 51383406 Proglumetacin maleate is a Commodity code with minimal recent state and local procurement activity aligned to its nominal pharmaceutical scope. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems for community health initiatives, a category distinctly outside proglumetacin maleate's pharmaceutical classification. The mismatch suggests either a tagging error in the county's procurement system or that this code does not reflect actual buying patterns in state and local government. State and local purchasing offices use proglumetacin maleate codes infrequently, if at all, making this a low-activity area within the broader pharmaceutical and health-supply procurement landscape.

The Seminole County solicitation remains the only supported recent opportunity; it calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a two-year initial contract term and one-year renewal option. The IFB response deadline was July 26, 2023 (note: a date substantially earlier than the June 30, 2026 posting date, indicating potential data-entry error in the source). Vendors must provide unit pricing for each line item, cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace requirements. No explicit set-aside or disadvantaged-enterprise designation applies. Without additional recent opportunities across other jurisdictions, geographic spread cannot be reliably characterized beyond Florida; the code does not show sufficient current activity to support meaningful market evaluation.